<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(5)</volume><submitter>Armirotti A</submitter><pubmed_abstract>The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs. We investigated the mechanism of inhibition of human NAAA by substituted β-lactones. We characterized pharmacologically a representative member of this class, ARN077, and showed, using high-resolution liquid chromatography-tandem mass spectrometry, that this compound forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pagination>422-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4025845</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.</pubmed_title><pmcid>PMC4025845</pmcid><pubmed_authors>Karacsonyi C</pubmed_authors><pubmed_authors>Bertozzi F</pubmed_authors><pubmed_authors>Tarzia G</pubmed_authors><pubmed_authors>Ponzano S</pubmed_authors><pubmed_authors>Romeo E</pubmed_authors><pubmed_authors>Dionisi M</pubmed_authors><pubmed_authors>Garau G</pubmed_authors><pubmed_authors>Tarozzo G</pubmed_authors><pubmed_authors>Bandiera T</pubmed_authors><pubmed_authors>Mor M</pubmed_authors><pubmed_authors>Armirotti A</pubmed_authors><pubmed_authors>Mengatto L</pubmed_authors><pubmed_authors>Piomelli D</pubmed_authors><pubmed_authors>Reggiani A</pubmed_authors></additional><is_claimable>false</is_claimable><name>β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.</name><description>The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs. We investigated the mechanism of inhibition of human NAAA by substituted β-lactones. We characterized pharmacologically a representative member of this class, ARN077, and showed, using high-resolution liquid chromatography-tandem mass spectrometry, that this compound forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 May</publication><modification>2025-04-04T08:41:59.8Z</modification><creation>2019-03-27T01:28:29Z</creation></dates><accession>S-EPMC4025845</accession><cross_references><pubmed>24900487</pubmed><doi>10.1021/ml300056y</doi></cross_references></HashMap>